Oxygenta Pharmaceutical Ltd - Board Meeting Outcome for Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 ('Listing Regulations')

Pursuant to Regulation 30 read with Part A of Schedule III of the Listing Regulations, we hereby inform you that the Board of Directors of the Company at its Board Meeting held today, April 08, 2024, inter-alia, considered and approved the following: